Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome

International Journal of Molecular Sciences

Volumn 18, Issue 2, 2017, Pages

  Alwahsh, Salamah M ^a,b   Dwyer, Benjamin J ^b   Forbes, Shareen ^c   van Thiel, David H ^d   Starkey Lewis, Philip J ^b   Ramadori, Giuliano ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d Advanced Liver and Gastrointestinal Disease Center   (United States)

Author keywords

Alcohol; Fatty liver; Insulin resistance; Obesity; Type II diabetes mellitus (T2DM)

Indexed keywords

ACYL COENZYME A OXIDASE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALCOHOL; ALPHA AMYLASE PANCREAS ISOENZYME; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; CREATININE; CYTOCHROME P450 2E1; FATTY ACID SYNTHASE; FRUCTOKINASE; FRUCTOSE; GLUCAGON; GLUCOSE; I KAPPA B KINASE ALPHA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HOMEOSTASIS MODEL ASSESSMENT; HYPERINSULINEMIA; INSULIN RESISTANCE; INTRAPERITONEAL FAT; LIPID DIET; LIVER WEIGHT; LOW FAT DIET; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; COMPLICATION; DISEASE MODEL; ENZYMOLOGY; FATTY LIVER; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; LIPID METABOLISM; LIVER; METABOLISM; OBESITY; ORGAN SIZE; PANCREAS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ETHANOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY LIVER; FRUCTOSE; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OBESITY; ORGAN SIZE; PANCREAS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; WEIGHT GAIN;

EID: 85013936229     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18020285     Document Type: Article

References (68)

1. Masarone, M.; Federico, A.; Abenavoli, L.; Loguercio, C.; Persico, M. Non alcoholic fatty liver: epidemiology and natural history. Rev. Recent Clin. Trials 2014, 9, 126–133. [CrossRef] [PubMed]
2. Adams, L.A.; Waters, O.R.; Knuiman, M.W.; Elliott, R.R.; Olynyk, J.K. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An eleven-year follow-up study. Am. J. Gastroenterol. 2009, 104, 861–867. [CrossRef] [PubMed]
3. Wei, J.L.; Leung, J.C.-F.; Loong, T.C.-W.; Wong, G.L.-H.; Yeung, D.K.-W.; Chan, R.S.-M.; Chan, H.L.-Y.; Chim, A.M.-L.; Woo, J.; Chu, W.C.-W.; et al. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. Am. J. Gastroenterol. 2015, 110, 1306–1314. [CrossRef] [PubMed]
4. Leite, N.C.; Salles, G.F.; Araujo, A.L.E.; Villela-Nogueira, C.A.; Cardoso, C.R.L. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 2009, 29, 113–119. [CrossRef] [PubMed]
5. Newton, K.P.; Hou, J.; Crimmins, N.A.; Lavine, J.E.; Barlow, S.E.; Xanthakos, S.A.; Africa, J.; Behling, C.; Donithan, M.; Clark, J.M.; et al. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. JAMA Pediatr. 2016, 170, e161971. [CrossRef] [PubMed]
6. Liangpunsakul, S.; Chalasani, N. What should we recommend to our patients with NAFLD regarding alcohol use? Am. J. Gastroenterol. 2012, 107, 976–978. [CrossRef]
7. Arslanian, S.A.; Saad, R.; Lewy, V.; Danadian, K.; Janosky, J. Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002, 51, 3014–3019. [CrossRef] [PubMed]
8. Svedberg, J.; Björntorp, P.; Smith, U.; Lönnroth, P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 1990, 39, 570–574. [CrossRef] [PubMed]
9. Kotronen, A.; Juurinen, L.; Tiikkainen, M.; Vehkavaara, S.; Yki-Järvinen, H. Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes. Gastroenterology 2008, 135, 122–130. [CrossRef] [PubMed]
10. Jones, C.N.; Pei, D.; Staris, P.; Polonsky, K.S.; Chen, Y.D.; Reaven, G.M. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J. Clin. Endocrinol. Metab. 1997, 82, 1834–1838. [CrossRef] [PubMed]
11. Duckworth, W.C.; Bennett, R.G.; Hamel, F.G.; Affairs, V. Insulin Degradation: Progress and Potential 1. Endocr. Rev. 1998, 19, 608–624.
12. Miyaaki, H.; Ichikawa, T.; Taura, N.; Miuma, S.; Honda, T.; Shibata, H.; Toriyama, K.; Nakao, K. Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver Disease. Intern. Med. 2016, 55, 1049–1054. [CrossRef] [PubMed]
13. Camporez, J.P.G.; Kanda, S.; Petersen, M.C.; Jornayvaz, F.R.; Samuel, V.T.; Bhanot, S.; Petersen, K.F.; Jurczak, M.J.; Shulman, G.I. ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content. J. Lipid Res. 2015, 56, 526–536. [CrossRef] [PubMed]
14. Yamauchi, T.; Kamon, J.; Minokoshi, Y.; Ito, Y.; Waki, H.; Uchida, S.; Yamashita, S.; Noda, M.; Kita, S.; Ueki, K.; et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8, 1288–1295. [CrossRef] [PubMed]
15. Chen, H.; Hamel, F.G.; Siford, G.; Duckworth, W.C. Alteration of rat hepatic insulin metabolism by glyburide and glipizide. J. Pharmacol. Exp. Ther. 1993, 264, 1293–1298. [PubMed]
16. Tiikkainen, M.; Häkkinen, A.-M.; Korsheninnikova, E.; Nyman, T.; Mäkimattila, S.; Yki-Järvinen, H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004, 53, 2169–2176. [CrossRef] [PubMed]
17. García-Monzón, C.; Lo Iacono, O.; Mayoral, R.; González-Rodríguez, A.; Miquilena-Colina, M.E.; Lozano-Rodríguez, T.; García-Pozo, L.; Vargas-Castrillón, J.; Casado, M.; Boscá, L.; et al. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. J. Hepatol. 2011, 54, 142–152. [CrossRef] [PubMed]
18. Basu, S.; Yoffe, P.; Hills, N.; Lustig, R.H. The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data. PLoS ONE 2013, 8, e57873. [CrossRef] [PubMed]
19. Lozano, I.; Van der Werf, R.; Bietiger, W.; Seyfritz, E.; Peronet, C.; Pinget, M.; Jeandidier, N.; Maillard, E.; Marchioni, E.; Sigrist, S.; et al. High-fructose and high-fat diet-induced disorders in rats: Impact on diabetes risk, hepatic and vascular complications. Nutr. Metab. 2016, 13, 15. [CrossRef] [PubMed]
20. Lê, K.A.; Ith, M.; Kreis, R.; Faeh, D.; Bortolotti, M.; Tran, C.; Boesch, C.; Tappy, L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 2009, 89, 1760–1765. [CrossRef] [PubMed]
21. Wu, T.; Giovannucci, E.; Pischon, T.; Hankinson, S.E.; Ma, J.; Rifai, N.; Rimm, E.B. Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am. J. Clin. Nutr. 2004, 80, 1043–1049. [PubMed]
22. Landmann, M.; Wagnerberger, S.; Kanuri, G.; Ziegenhardt, D.; Bergheim, I. Beer Is Less Harmful for the Liver than Plain Ethanol: Studies in Male Mice Using a Binge-Drinking Model. Alcohol Alcohol. 2015, 50, 493–500. [CrossRef] [PubMed]
23. Godos, J.; Federico, A.; Dallio, M.; Scazzina, F. Mediterranean diet and nonalcoholic fatty liver disease: Molecular mechanisms of protection. Int. J. Food Sci. Nutr. 2016. [CrossRef] [PubMed]
24. Boesch, C.; Elsing, C.; Wegmüller, H.; Felblinger, J.; Vock, P.; Reichen, J. Effect of ethanol and fructose on liver metabolism a dynamic 31Phosphorus magnetic resonance spectroscopy study in normal volunteers. Magn. Reson. Imaging 1997, 15, 1067–1077. [CrossRef]
25. Uzuegbu, U.E.; Onyesom, I. Fructose-induced increase in ethanol metabolism and the risk of Syndrome X in man. C. R. Biol. 2009, 332, 534–538. [CrossRef] [PubMed]
26. Song, M.; Chen, T.; Prough, R.A.; Cave, M.C.; McClain, C.J. Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response. Alcohol. Clin. Exp. Res. 2016. [CrossRef] [PubMed]
27. Shulga, N.; Pastorino, J.G. Mitoneet mediates TNFα-induced necroptosis promoted by exposure to fructose and ethanol. J. Cell Sci. 2014, 127, 896–907. [CrossRef] [PubMed]
28. Alwahsh, S.M.; Xu, M.; Schultze, F.C.; Wilting, J.; Mihm, S.; Raddatz, D.; Ramadori, G. Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats. PLoS ONE 2014, 9, e104220. [CrossRef] [PubMed]
29. Wang, J.; Luben, R.; Khaw, K.-T.; Bingham, S.; Wareham, N.J.; Forouhi, N.G. Dietary energy density predicts the risk of incident type 2 diabetes: the European Prospective Investigation of Cancer (EPIC)-Norfolk Study. Diabetes Care 2008, 31, 2120–2125. [CrossRef] [PubMed]
30. Sideri, A.; Stavrakis, D.; Bowe, C.; Shih, D.Q.; Fleshner, P.; Arsenescu, V.; Arsenescu, R.; Turner, J.R.; Pothoulakis, C.; Karagiannides, I. Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1. Am. J. Physiol. Gastrointest. Liver Physiol. 2015, 308, G591–G604. [CrossRef] [PubMed]
31. Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.; Dyachenko, A.; Zhang, W.; et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119, 1322–1334. [CrossRef] [PubMed]
32. Fabbrini, E.; Sullivan, S.; Klein, S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 2010, 51, 679–689. [CrossRef] [PubMed]
33. Lieber, C.S.; Leo, M.A.; Mak, K.M.; Decarli, L.M.; Sato, S. Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity. Hepatology 1985, 5, 561–572. [CrossRef] [PubMed]
34. Miyakawa, H.; Iida, S.; Leo, M.; Greenstein, R.; Zimmon, D.; Lieber, C. Citation Pathogenesis of precirrhotic portal hypertension in alcohol-fed baboons. Gastroenterology 1985, 88, 143–150. [CrossRef]
35. Lieber, C.S.; Decarli, L.M.; Sorrell, M.F. Experimental methods of ethanol administration. Hepatology 1989, 10, 501–510. [CrossRef] [PubMed]
36. Lieber, C.S.; DeCarli, L.M. Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol. 1989, 24, 197–211. [PubMed]
37. Leeman, R.F.; Heilig, M.; Cunningham, C.L.; Stephens, D.N.; Duka, T.; O’Malley, S.S. Ethanol Consumption: How Should We Measure It? Achieving Consilience between Human and Animal Phenotypes. Addict. Biol. 2010, 15, 109–124. [CrossRef] [PubMed]
38. Sellmann, C.; Priebs, J.; Landmann, M.; Degen, C.; Engstler, A.J.; Jin, C.J.; Gärttner, S.; Spruss, A.; Huber, O.; Bergheim, I. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. J. Nutr. Biochem. 2015, 26, 1183–1192. [CrossRef] [PubMed]
39. Louvet, A.; Mathurin, P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 231–242. [CrossRef] [PubMed]
40. Nakamuta, M.; Kohjima, M.; Morizono, S.; Kotoh, K.; Yoshimoto, T.; Miyagi, I.; Enjoji, M. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2005, 16, 631–635. [PubMed]
41. McCullough, A.J. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2006, 40, S17–S29. [PubMed]
42. Alwahsh, S.M.; Gebhardt, R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch. Toxicol. 2016. [CrossRef] [PubMed]
43. Ishimoto, T.; Lanaspa, M.A.; Rivard, C.J.; Roncal-Jimenez, C.A.; Orlicky, D.J.; Cicerchi, C.; Mcmahan, R.H.; Abdelmalek, M.F.; Rosen, H.R.; Jackman, M.R.; et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 2013, 58, 1632–1643. [CrossRef] [PubMed]
44. Gao, W.; Pan, B.; Liu, L.; Huang, X.; Liu, Z.; Tian, J. Alcohol exposure increases the expression of cardiac transcription factors through ERK1/2-mediated histone3 hyperacetylation in H9C2 cells. Biochem. Biophys. Res. Commun. 2015, 466, 670–675. [CrossRef] [PubMed]
45. Jiao, P.; Feng, B.; Li, Y.; He, Q.; Xu, H. Hepatic ERK activity plays a role in energy metabolism. Mol. Cell. Endocrinol. 2013, 375, 157–166. [CrossRef] [PubMed]
46. Weng, L.P.; Smith, W.M.; Brown, J.L.; Eng, C. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum. Mol. Genet. 2001, 10, 605–616. [CrossRef] [PubMed]
47. Jaiswal, N.; Maurya, C.K.; Pandey, J.; Rai, A.K.; Tamrakar, A.K. Fructose-induced ROS generation impairs glucose utilization in L6 skeletal muscle cells. Free Radic. Res. 2015, 5762, 1–14. [CrossRef] [PubMed]
48. Hirosumi, J.; Tuncman, G.; Chang, L.; Görgün, C.Z.; Uysal, K.T.; Maeda, K.; Karin, M.; Hotamisligil, G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420, 333–336. [CrossRef] [PubMed]
49. Lanaspa, M.A.; Ishimoto, T.; Li, N.; Cicerchi, C.; Orlicky, D.J.; Ruzycki, P.; Ruzicky, P.; Rivard, C.; Inaba, S.; Roncal-Jimenez, C.A.; et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat. Commun. 2013, 4, 2434. [PubMed]
50. Commerford, S.R.; Bizeau, M.E.; McRae, H.; Jampolis, A.; Thresher, J.S.; Pagliassotti, M.J. Hyperglycemia compensates for diet-induced insulin resistance in liver and skeletal muscle of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281, R1380–R1389. [PubMed]
51. Castro, M.C.; Francini, F.; Schinella, G.; Caldiz, C.I.; Zubiría, M.G.; Gagliardino, J.J.; Massa, M.L. Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system. Clin. Sci. 2012, 123, 681–692. [CrossRef] [PubMed]
52. Spruss, A.; Henkel, J.; Kanuri, G.; Blank, D.; Püschel, G.P.; Bischoff, S.C.; Bergheim, I. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. Mol. Med. 2012, 18, 1346–1355. [CrossRef] [PubMed]
53. Jaspan, J.; Polonsky, K. Glucose Ingestion in Dogs Alters the Hepatic Extraction of Insulin. J. Clin. Investig. 1982, 69, 516–525. [CrossRef] [PubMed]
54. Flier, J.S.; Minaker, K.L.; Landsberg, L.; Young, J.B.; Pallotta, J.; Rowe, J.W. Impaired in vivo insulin clearance in patients with severe target-cell resistance to insulin. Diabetes 1982, 31, 132–135. [CrossRef] [PubMed]
55. Sookoian, S.; Pirola, C.J. How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals? Gastroenterology 2016, 150, 1698–1703. [CrossRef]
56. Joosten, M.M.; Beulens, J.W.J.; Kersten, S.; Hendriks, H.F.J. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: A randomised, crossover trial. Diabetologia 2008, 51, 1375–1381. [CrossRef] [PubMed]
57. Kanuri, G.; Landmann, M.; Priebs, J.; Spruss, A.; Löscher, M.; Ziegenhardt, D.; Röhl, C.; Degen, C.; Bergheim, I. Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice. Eur. J. Nutr. 2016, 55, 1153–1164. [CrossRef] [PubMed]
58. Jo, Y.H.; Choi, K.-M.; Liu, Q.; Kim, S.B.; Ji, H.-J.; Kim, M.; Shin, S.-K.; Do, S.-G.; Shin, E.; Jung, G.; et al. Anti-Obesity Effect of 6,8-Diprenylgenistein, an Isoflavonoid of Cudrania tricuspidata Fruits in High-Fat Diet-Induced Obese Mice. Nutrients 2015, 7, 10480–10490. [CrossRef] [PubMed]
59. Ibrahim, S.M.; El Denshary, E.S.; Abdallah, D.M.; Popkin, B.; Malik, V.; Popkin, B.; Bray, G.; Despres, J.; Willett, W.; Grundy, S.; et al. Geraniol, Alone and in Combination with Pioglitazone, Ameliorates Fructose-Induced Metabolic Syndrome in Rats via the Modulation of Both Inflammatory and Oxidative Stress Status. PLoS ONE 2015, 10, e0117516. [CrossRef] [PubMed]
60. Chen, X.; Sebastian, B.M.; Tang, H.; McMullen, M.M.; Axhemi, A.; Jacobsen, D.W.; Nagy, L.E. Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 2009, 49, 1554–1562. [CrossRef] [PubMed]
61. Papamiltiadous, E.S.; Roberts, S.K.; Nicoll, A.J.; Ryan, M.C.; Itsiopoulos, C.; Salim, A.; Tierney, A.C. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): Study protocol. BMC Gastroenterol. 2016, 16, 14. [CrossRef] [PubMed]
62. Cakir, M.; Akbulut, U.E.; Okten, A. Association between Adherence to the Mediterranean Diet and Presence of Nonalcoholic Fatty Liver Disease in Children. Child. Obes. 2016, 12, 279–285. [CrossRef] [PubMed]
63. Heikkinen, S.; Argmann, C.A.; Champy, M.-F.; Auwerx, J. Evaluation of glucose homeostasis. Curr. Protoc. Mol. Biol. 2007. [CrossRef]
64. Xu, M.; Alwahsh, S.M.; Ramadori, G.; Kollmar, O.; Slotta, J.E. Upregulation of hepatic melanocortin 4 receptor during rat liver regeneration. J. Surg. Res. 2016, 203, 222–230. [CrossRef] [PubMed]
65. Alwahsh, S.M.; Xu, M.; Seyhan, H.A.; Ahmad, S.; Mihm, S.; Ramadori, G.; Schultze, F.C. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J. Gastroenterol. 2014, 20, 1807–1821. [CrossRef] [PubMed]
66. Folch, J.; Lees, M.; Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [PubMed]
67. Ulusoy, E.; Eren, B. Histological changes of liver glycogen storage in mice (Mus musculus) caused by high-protein diets. Histol. Histopathol. 2006, 21, 925–930. [PubMed]
68. Gotoh, M.; Maki, T.; Kiyoizumi, T.; Satomi, S.; Monaco, A.P. An improved method for isolation of mouse pancreatic islets. Transplantation 1985, 40, 437–438. [CrossRef] [PubMed]